Electropharmacologic effects and pharmacokinetics of almokalant, a new class III antiarrhythmic, in patients with healed or healing myocardial infarcts and complex ventricular arrhythmias

This publication has 13 references indexed in Scilit:

• Prolonged Action Potential Duration and Positive Inotropy Induced by the Novel Class III Antiarrhythmic Agent H 234/09 (Almokalant) in Isolated Human Ventricular Muscle
  Journal of Cardiovascular Pharmacology, 1991
• Standards for analysis of ventricular late potentials using high-resolution or signal-averaged electrocardiography: A statement by a task force committee of the European Society of Cardiology, the American Heart Association, and the American College of Cardiology
  Journal of the American College of Cardiology, 1991
• Class III antiarrhythmic agents have a lot of potential but a long way to go. Reduced effectiveness and dangers of reverse use dependence.
  Circulation, 1990
• Proarrhythmia, arrhythmogenesis or aggravation of arrhythmia—A status report, 1987
  The American Journal of Cardiology, 1987
• Clinical types of proarrhythmic response to antiarrhythmic drugs
  The American Journal of Cardiology, 1987
• Effect of excision of ventricular myocardium on delayed potentials detected by the signal-averaged electrocardiogram in patients with ventricular tachycardia
  The American Journal of Cardiology, 1987
• Technique for maximizing the frequency response of the signal averaged Frank vectorcardiogram
  Journal of Biomedical Engineering, 1986
• Body surface late potentials: effects of endocardial resection in patients with ventricular tachycardia.
  Circulation, 1984
• Effects of antiarrhythmic surgery on late ventricular potentials recorded by precordial signal averaging in patients with ventricular tachycardia
  American Heart Journal, 1982
• Use of signals in the terminal QRS complex to identify patients with ventricular tachycardia after myocardial infarction.
  Circulation, 1981